You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AAV2-hAADC

Showing 1 - 25 of 339
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Aromatic Amino Acid Decarboxylase Deficiency Trial in Taipei (AAV2-hAADC)

Active, not recruiting
  • Aromatic Amino Acid Decarboxylase Deficiency
  • AAV2-hAADC
  • Taipei, Taiwan
    National Taiwan University Hospital
Nov 15, 2021

Aromatic L-amino Acid Decarboxylase (AADC) Deficiency Trial in Taipei (gene therapy)

Active, not recruiting
  • Aromatic L-amino Acid Decarboxylase (AADC) Deficiency
  • gene therapy
  • Taipei, Taiwan
    National Taiwan University Hospital
Aug 4, 2021

AADC Deficiency Trial in San Francisco, Columbus (AAV2-hAADC)

Recruiting
  • AADC Deficiency
  • AAV2-hAADC
  • San Francisco, California
  • +2 more
Jan 14, 2022

To Evaluate the Scaling Clinical Study of AAV2-RPE65 Gene Therapy Agent (LX101) in Patients With Congenital Amaurosis (LCA)

Not yet recruiting
  • To Evaluate the Scaling Clinical Study of AAV2-RPE65 Gene Therapy Agent (LX101) in Patients With Congenital Amaurosis (LCA)
  • (no location specified)
Aug 29, 2023

Treatment of Symptoms of Grade 2 and Grade 3 Late Xerostomia From Salivary Gland Hypofunction Caused by Radiotherapy for Cancer

Recruiting
  • Treatment of Symptoms of Grade 2 and Grade 3 Late Xerostomia From Salivary Gland Hypofunction Caused by Radiotherapy for Cancer of the Oropharynx
  • AAV2-hAQP1 Concentration 1
  • +2 more
  • Charlotte, North Carolina
    Atrium Health
Jun 22, 2023

Parkinson's Disease Trial run by the National Institute of Neurological Disorders and Stroke (NINDS) (Convection enhanced

Completed
  • Parkinson's Disease
  • Convection enhanced delivery/AAV2-GDNF
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 26, 2023

Parkinson's Disease Trial in San Francisco, Pittsburgh (VY-AADC01)

Completed
  • Parkinson's Disease
  • VY-AADC01
  • San Francisco, California
  • +1 more
Feb 28, 2020

Multiple System Atrophy Trial in Irvine, Columbus (AAV2-GDNF gene therapy, Sham (Placebo) Surgery)

Recruiting
  • Multiple System Atrophy
  • AAV2-GDNF gene therapy
  • Sham (Placebo) Surgery
  • Irvine, California
  • +1 more
Jan 18, 2023

Parkinson's Disease Trial in San Francisco, Chicago (CERE-120: AAV2-NTN)

Completed
  • Parkinson's Disease
  • CERE-120: AAV2-NTN
  • San Francisco, California
  • +1 more
Nov 8, 2022

Long Term Follow-Up Gene Therapy Study for XLRP RPGR

Recruiting
  • X-Linked Retinitis Pigmentosa
  • AAV-RPGR
  • Boston, Massachusetts
  • +3 more
Dec 5, 2022

Radiation-Induced Parotid Gland Hypofunction, Xerostomia Due to Radiotherapy, Head Neck Cancer Trial in Canada, United States

Active, not recruiting
  • Radiation-Induced Parotid Gland Hypofunction
  • +2 more
  • AAV2hAQP1: 1 x 10^11 vg/gland (single gland)
  • +7 more
  • Stanford, California
  • +5 more
Dec 22, 2022

Subjects Who Received Voretigene Neparvovec-rzyl (AAV2-hRPE65v2)

Active, not recruiting
  • Inherited Retinal Dystrophy Due to RPE65 Mutations
  • AAV2-hRPE65v2
  • (no location specified)
Dec 9, 2021

Age-Related Macular Degeneration Trial in Toronto (NG101 AAV gene therapy)

Not yet recruiting
  • Age-Related Macular Degeneration
  • NG101 AAV gene therapy
  • Toronto, Ontario, Canada
    Vitreous Retina Macula Specialists of Toronto
Aug 2, 2023

Pompe Disease Trial in Saint Louis, New York, Durham (ACTUS-101)

Recruiting
  • Pompe Disease
  • ACTUS-101
  • Saint Louis, Missouri
  • +2 more
May 25, 2022

Idiopathic Parkinson's Disease Trial in United States (CERE-120 (Adeno-Associated Virus Serotype 2 [AAV2]-Neurturin [NTN]), Sham

Completed
Has Results
  • Idiopathic Parkinson's Disease
  • CERE-120 (Adeno-Associated Virus Serotype 2 [AAV2]-Neurturin [NTN])
  • Sham Surgery
  • Birmingham, Alabama
  • +8 more
Nov 8, 2022

Parkinson's Disease Trial in Irvine, San Francisco, Columbus (AAV2-GDNF)

Recruiting
  • Parkinson's Disease
  • AAV2-GDNF
  • Irvine, California
  • +2 more
Feb 8, 2022

Inherited Retinal Dystrophy Due to RPE65 Mutations, Leber Congenital Amaurosis Trial in Iowa City, Philadelphia

Active, not recruiting
Has Results
  • Inherited Retinal Dystrophy Due to RPE65 Mutations
  • Leber Congenital Amaurosis
  • AAV2-hRPE65v2,voretigene neparvovec-rzyl
  • Iowa City, Iowa
  • +1 more
Dec 9, 2021

Heart Failure, Diastolic, Heart Failure With Preserved Ejection Fraction Trial in Durham, Dallas (AAV1/SERCA2a)

Recruiting
  • Heart Failure, Diastolic
  • Heart Failure With Preserved Ejection Fraction
  • AAV1/SERCA2a
  • Durham, North Carolina
  • +1 more
Sep 23, 2023

Parkinson's Disease Trial in United States (VY-AADC02, Sham (Placebo) Surgery)

Active, not recruiting
  • Parkinson's Disease
  • VY-AADC02
  • Sham (Placebo) Surgery
  • Irvine, California
  • +19 more
Mar 17, 2022

Fabry Disease Trial in United Kingdom, United States (ST-920)

Recruiting
  • Fabry Disease
  • ST-920
  • Irvine, California
  • +20 more
Feb 1, 2023

X-Linked Retinitis Pigmentosa Trial in United Kingdom, United States (AAV2/5-RPGR)

Completed
  • X-Linked Retinitis Pigmentosa
  • AAV2/5-RPGR
  • Boston, Massachusetts
  • +4 more
Dec 15, 2021

Lysosomal Diseases, Gangliosidosis, GM1 Trial run by the NHGRI (biological, drug, diagnostic test, other, procedure, behavioral)

Recruiting
  • Lysosomal Diseases
  • +2 more
  • AAV9-GLB1
  • +20 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 19, 2023

Alzheimer's Disease Trial in San Diego, Cleveland (AAV2-BDNF Gene Therapy)

Recruiting
  • Alzheimer's Disease
  • AAV2-BDNF Gene Therapy
  • San Diego, California
  • +1 more
Sep 1, 2021

AAV2hAQP1 for Radiation Induced Xerostomia

Enrolling by invitation
  • Radiation-induced Xerostomia
    • Stanford, California
    • +3 more
    Dec 22, 2022

    GSD1 Trial in Worldwide (DTX401)

    Completed
    Has Results
    • GSD1
    • DTX401
    • steroid regimen
    • Farmington, Connecticut
    • +5 more
    Oct 25, 2022